Skip to search formSkip to main contentSkip to account menu

Lilly A 217

Known as: Lilly-A-217, LY A 217, Lilly A-217 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background Tildrakizumab (TIL), a high-affinity anti–interleukin-23p19 monoclonal antibody, is approved for moderate-to-severe… 
Review
2017
Review
2017
In this review, I consider the varied mechanisms in cortical bone that help preserve its integrity and how they deteriorate with… 
2016
2016
Aim: Whether high platelet reactivity (HPR) immediately after diagnostic angiography is associated with worse coronary… 
2011
2011
Background— Prior randomized trials have shown reduced bleeding with bivalirudin compared with unfractionated heparin (UFH) in… 
2010
2010
ObjectivesOur aim was to investigate the safety and efficacy of transradial approach, predictors of bleeding complications, and… 
Review
2009
Review
2009
The increased rates of both overweight and obesity reported in severely mentally‐ill patients are prevalently due to the use of… 
2009
2009
A United States patent must provide a "written description" of the invention claimed therein. In its earliest implementation, a… 
Review
2008
Review
2008
The combination of a long undetected illness and significant psychosocial impairment renders early identification and… 
2001
2001
The University of Toronto (UT) and its affiliated hospitals have become embroiled in another controversy regarding their attitude…